Arkema's earnings, volumes decline, sees market uncertainty weighing heavily on demand
11:55 AM | February 27, 2020 | Mark Thomas
Company flags up disruption due to COVID-19 outbreak, estimates impact on EBITDA of €20 million by end-February.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.